A new algorithm predicting imminent disease progression in advanced NSCLC patients by machine-learning integration of five serum biomarkers.
Abstract accepted for online publication in Proceedings of the ASCO Annual Meeting, June 1-5, 2018 in Chicago, Illinois.
Link to Abstract